欧美日韩成人一区二区三区,成人污污污WWW网站免费直播,久久综久久美利坚合众国,国产精品人妻一区二区三区四区

首頁 > 產(chǎn)品目錄 > 信號通路 > Protein Tyrosine Kinase/RTK > EGFR > 奧希替尼 | 邁瑞替尼

奧希替尼 | 邁瑞替尼

ChemLeader 98+%

Osimertinib | Mereletinib | AZD-9291

產(chǎn)品編號:CL2211 CAS No.:1421373-65-0 MDLNo: 分子式:C28H33N7O2 分子量: 499.62
規(guī)格 庫存 目錄價 會員專享價 數(shù)量
250 mg In-stock ¥300.00 登錄后可見
- +
1 g In-stock ¥850.00 登錄后可見
- +

化學(xué)品安全說明書(MSDS)

下載MSDS

質(zhì)檢證書(COA)

  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻
基本信息
英文名稱 Osimertinib | Mereletinib | AZD-9291
中文名稱奧希替尼 | 邁瑞替尼
CAS號1421373-65-0
分子式C28H33N7O2
分子量 499.62
外觀Off-white powder
儲存條件 Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產(chǎn)品詳情

Osimertinib, also known as AZD-9291 and Mereletinib, is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines. Osimertinib was approved in Nov. 2015 by FDA.

在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時間: 工作日 9:00-18:00
开江县| 泉州市| 特克斯县| 鄄城县| 恩施市| 浠水县| 临武县| 淮滨县| 金湖县| 景谷| 双牌县| 庆安县| 修文县| 靖宇县| 宜君县| 凤台县| 成都市| 新晃| 湖州市| 阿拉尔市| 宝山区| 柯坪县| 平潭县| 灵台县| 鄂尔多斯市| 溆浦县| 略阳县| 沙田区| 新巴尔虎右旗| 武穴市| 义马市| 苍梧县| 蓬安县| 忻城县| 高密市| 巩义市| 葫芦岛市| 沁源县| 洛南县| 天门市| 南京市|